# Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

> **NCT01250210** · PHASE2 · COMPLETED · sponsor: **Agile Therapeutics** · enrollment: 123 (actual)

## Conditions studied

- Ovulation Suppression

## Interventions

- **DRUG:** levonorgestrel and ethinyl estradiol

## Key facts

- **NCT ID:** NCT01250210
- **Lead sponsor:** Agile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250210, "Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01250210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*